Angiotensin receptor neprilysin inhibitor LCZ696: Pharmacology, pharmacokinetics and clinical development
© 2017 Future Medicine Ltd.Heart failure still has a significant disease burden with poor outcomes worldwide despite advances in therapy. The standard therapies have been focused on blockade of renin-angiotensin-aldosterone system with angiotensin-converting enzyme inhibitors, angiotensin receptor b...
| Main Authors: | Hua, Y., Wang, I., Liu, B., Kelly, D., Reid, Christopher, Liew, D., Zhou, Y., Wang, B. |
|---|---|
| Format: | Journal Article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/51401 |
Similar Items
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
by: Potier, L., et al.
Published: (2017)
by: Potier, L., et al.
Published: (2017)
Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability
by: Mohd Zaffarin, Anis Syauqina, et al.
Published: (2020)
by: Mohd Zaffarin, Anis Syauqina, et al.
Published: (2020)
Investigating the implementation and impact of “Better Care Better Value” prescribing policy for Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for treating hypertension in the UK primary care setting
by: Baker, Amanj
Published: (2016)
by: Baker, Amanj
Published: (2016)
The effects of Angiotensin-converting-enzyme inhibitor (Enalapril) on gentamicin nephrotoxicity
by: Al-Ani, Imad Matloub Dally, et al.
Published: (2014)
by: Al-Ani, Imad Matloub Dally, et al.
Published: (2014)
An Islamic monetary theory of value and equation of exchange: evidence from Egypt (696–1517)
by: Abdullah, Adam
Published: (2016)
by: Abdullah, Adam
Published: (2016)
The effects of Angiotensin-Converting-Enzyme Inhibitor (Captopril) on Gentamicin Nephrotoxicity in rats
by: Al-Attiyah, Zainab M, et al.
Published: (2013)
by: Al-Attiyah, Zainab M, et al.
Published: (2013)
Gene polymorphisms of angiotensin-converting enzyme, angiotensin type 1 receptor and α-adducin associated with renin angiotensin-aldosterone system in Malaysian end-stage renal disease patients
by: Ali, Aisyah
Published: (2012)
by: Ali, Aisyah
Published: (2012)
Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
by: Ayob, Azizi, et al.
Published: (2006)
by: Ayob, Azizi, et al.
Published: (2006)
An evaluation of DREADD receptor pharmacology in recombinant cells and astrocytes
by: Carpenter, Jessica
Published: (2020)
by: Carpenter, Jessica
Published: (2020)
Kinetic studies of dopamine D2 receptor molecular pharmacology
by: Keen, Alastair C.
Published: (2021)
by: Keen, Alastair C.
Published: (2021)
Vascular change and opposing effects of the angiotensin type 2 receptor in a mouse model of vascular cognitive impairment
by: Füchtemeier, Martina, et al.
Published: (2015)
by: Füchtemeier, Martina, et al.
Published: (2015)
Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
Pharmacological interactions between phenylbenzothiazoles and aryl hydrocarbon receptor (AhR)
by: Bazzi, Rana
Published: (2008)
by: Bazzi, Rana
Published: (2008)
Pharmacological characterisation of the fatty acid receptors GPR120 and FFA1
by: Watson, Sarah-Jane
Published: (2013)
by: Watson, Sarah-Jane
Published: (2013)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
Evaluation of angiotensin ii receptor blockers (ARBS) for drug formulary using objective scoring analytical tool.
by: Lim, Ming Tsuey
Published: (2011)
by: Lim, Ming Tsuey
Published: (2011)
The role of dihydrosphingolipids in disease
by: Magaye, R., et al.
Published: (2018)
by: Magaye, R., et al.
Published: (2018)
Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug
interactions
by: Cherkaoui-Rbati, Mohammed, et al.
Published: (2017)
by: Cherkaoui-Rbati, Mohammed, et al.
Published: (2017)
Do highly physically active workers die early? A systematic review with meta-analysis of data from 193 696 participants
by: Coenen, P., et al.
Published: (2018)
by: Coenen, P., et al.
Published: (2018)
Design, synthesis and pharmacological evaluation of novel fluorescent ligands for the mu-opioid receptor
by: Marshall, William
Published: (2021)
by: Marshall, William
Published: (2021)
Angiotensin receptor blockers for erectile dysfunction in hypertensive men: a brief meta-analysis of
randomized control trials
by: Ismail, Shaiful Bahari, et al.
Published: (2019)
by: Ismail, Shaiful Bahari, et al.
Published: (2019)
Measuring ligand concentration where it matters: Assessing the “micro pharmacokinetic/pharmacodynamics” of adenosine receptor ligands
by: Lochray, Jack
Published: (2022)
by: Lochray, Jack
Published: (2022)
Cost-effectiveness of angiotensin-converting enzyme inhibitor-based compared to thiazide diuretic-based treatment in an elderly hypertensive population considering diabetes as a major comorbidity
by: Chowdhury, E., et al.
Published: (2015)
by: Chowdhury, E., et al.
Published: (2015)
A G protein-coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1/Y5 receptor heterodimers
by: Kilpatrick, Laura E., et al.
Published: (2015)
by: Kilpatrick, Laura E., et al.
Published: (2015)
Pharmacological analysis and structure determination of
7-methylcyanopindolol–bound b1-adrenergic receptor
by: Sato, Tomomi, et al.
Published: (2015)
by: Sato, Tomomi, et al.
Published: (2015)
Discovery of COVID-19 protein inhibitors in phenolic acids of azadirachta indica (neem) using docking and pharmacokinetics
by: Roney, Miah, et al.
Published: (2024)
by: Roney, Miah, et al.
Published: (2024)
COST-UTILITY ANALYSIS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-BASED TREATMENT COMPARED TO THIAZIDE DIURETIC-BASED TREATMENT IN AN ELDERLY HYPERTENSIVE POPULATION CONSIDERING MAJOR COMORBIDITIES AT THE COMMUNITY LEVEL
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
by: Guo, Q., et al.
Published: (2018)
by: Guo, Q., et al.
Published: (2018)
The safety pharmacology of Syk inhibitors: new preclinical screens to characterise cardiovascular adverse drug effects
by: Van Daele, Marieke
Published: (2024)
by: Van Daele, Marieke
Published: (2024)
In vivo pharmacological evaluation of a novel dual-target inhibitor and methylprednisolone as Alzheimer’s disease treatments
by: Zhang, Bocheng
Published: (2023)
by: Zhang, Bocheng
Published: (2023)
The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator
by: Brandish, P., et al.
Published: (2014)
by: Brandish, P., et al.
Published: (2014)
Phytochemical, Pharmacological And Pharmacokinetic Studies Of Phyllanthus Niruri Linn Lignans As Potential Antihyperuricemic Agents [QK861. V694 2008 f rb].
by: Murugaiyah, Vikneswaran
Published: (2008)
by: Murugaiyah, Vikneswaran
Published: (2008)
Pharmacokinetics of transfer of azithromycin into the breast milk of African mothers
by: Salman, S., et al.
Published: (2016)
by: Salman, S., et al.
Published: (2016)
The placental renin-angiotensin system and oxidative stress in pre-eclampsia
by: Mistry, H.D., et al.
Published: (2013)
by: Mistry, H.D., et al.
Published: (2013)
Pharmacokinetics and bioavailability of hydromorphone nasal spray
by: Lim, S, et al.
Published: (2008)
by: Lim, S, et al.
Published: (2008)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
by: Chin, K., et al.
Published: (2019)
by: Chin, K., et al.
Published: (2019)
In vivo study of the pharmacokinetic effect of amlodipine and gliclazide
by: Helal Uddin, A.B.M., et al.
Published: (2017)
by: Helal Uddin, A.B.M., et al.
Published: (2017)
The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders
by: Stepanov, V., et al.
Published: (2013)
by: Stepanov, V., et al.
Published: (2013)
The Study Of Syntactic Avoidance Of The Written Production Of Persian University Students Majoring In Teaching English As A Foreign Language [LB2372.E5 M696 2008 f rb].
by: Moghimizadeh, Reza Pasha
Published: (2008)
by: Moghimizadeh, Reza Pasha
Published: (2008)
Similar Items
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
by: Potier, L., et al.
Published: (2017) -
Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability
by: Mohd Zaffarin, Anis Syauqina, et al.
Published: (2020) -
Investigating the implementation and impact of “Better Care Better Value” prescribing policy for Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for treating hypertension in the UK primary care setting
by: Baker, Amanj
Published: (2016) -
The effects of Angiotensin-converting-enzyme inhibitor (Enalapril) on gentamicin nephrotoxicity
by: Al-Ani, Imad Matloub Dally, et al.
Published: (2014) -
An Islamic monetary theory of value and equation of exchange: evidence from Egypt (696–1517)
by: Abdullah, Adam
Published: (2016)